Renee Gala Insider Profile
4 Followers
Renee Gala, President & CEO, Director at Jazz Pharmaceuticals, holds 140.39K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 12.49K shares in Dexcom (Ticker: DXCM), holds 157.66K shares in Theravance Biopharma (Ticker: TBPH).
Renee Gala's Trading History
| JAZZJazz Pharmaceuticals | Nov 05, 2026 | President & CEO, Director | Uninformative Sell | 225.37K | $32.96M | |
| DXCMDexcom | Jun 01, 2026 | Director | Uninformative Buy | ― | $991.51K | |
| TBPHTheravance Biopharma | Nov 21, 2018 | ― | Uninformative Sell | 166.02K | $2.68M | |
| CORTCorcept Therapeutics | Mar 07, 2018 | Director | Informative Buy | 155.07K | $727.70K | |
| GOSSGossamer Bio | ― | Director | ― | ― |
You May Also Like
Renee Gala insider profile FAQ
What is the percentage of profitable transactions made by Renee Gala?
The percentage of profitable transactions made by Renee Gala is 80%.
What is the average return per transaction made by Renee Gala?
The average return per transaction made by Renee Gala is 33.50%.
What stocks does Renee Gala hold?
Renee Gala holds: JAZZ, CORT, DXCM, TBPH, GOSS stocks.
What was Renee Gala’s latest transaction?
Renee Gala’s latest transaction was an Uninformative Sell of $225.37K.
What was Renee Gala's most profitable transaction?
Renee Gala’s most profitable transaction was an Informative Buy of TBPH stock on August 17, 2015. The return on the trade was 131.70%.
What is Renee Gala's role in Jazz Pharmaceuticals?
Renee Gala's role in Jazz Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.